Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06831474 · ClinicalTrials.gov registry record · Phase 1
Excretion of Rivaroxaban in Human Breast Milk
A Phase 1 study of Breastfeeding and Postpartum, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06831474: Recruiting Phase 1 study of Breastfeeding and Postpartum, sponsored by Thomas Jefferson University.
NCT06831474 is a Phase 1 study of Breastfeeding and Postpartum that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 10 participants, below the 597-participant average among 36 other Breastfeeding trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06831474, a Phase 1 study of Breastfeeding and Postpartum, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the distribution of rivaroxaban into human milk at both therapeutic and prophylactic doses, and over time with repeated dosing.
Primary Outcome
Time/Concentration profile of rivaroxaban in breast milk prior to intake (0) and 3, 6, 12, 15 and 24 hours following morning dose on day 0-1
Conditions Studied
Interventions
- DRUG Rivaroxaban 10 MG Oral Tablet
- DRUG Rivaroxaban 20 MG Oral Tablet
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-07 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 1 |
What NCT06831474 shows while recruiting
NCT06831474 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 597-participant average among 36 other Breastfeeding trials with a reported enrollment target (98% lower).
The record links to 6 conditions, with Breastfeeding appearing as the primary indexed condition, and to 2 interventions - of which Rivaroxaban 10 MG Oral Tablet is the first listed.
NCT06831474 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06831474 about?
NCT06831474 is a clinical study titled "Excretion of Rivaroxaban in Human Breast Milk". The purpose of this study is to investigate the distribution of rivaroxaban into human milk at both therapeutic and prophylactic doses, and over time with repeated dosing.
What is the current status of trial NCT06831474?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2025-07. Estimated completion is 2026-07-31.
What conditions does trial NCT06831474 study?
This clinical trial studies the following conditions: Breastfeeding, Postpartum, Breast Milk Collection, VTE (Venous Thromboembolism), VTE Prophylaxis.
What interventions are being tested in trial NCT06831474?
The interventions under investigation include: Rivaroxaban 10 MG Oral Tablet (DRUG), Rivaroxaban 20 MG Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT06831474?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06831474 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breastfeeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06831474's enrollment target sits among peer trials
10 37th of 36 the lowest of 36 other Breastfeeding trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breastfeeding trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
RECRUITING
-
Furthering Equity Through Infant Feeding EDucation and Support
RECRUITING · NA
-
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
RECRUITING
-
Support Via Online Social Networks to Promote Safe Infant Care Practices
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia